SCHOLAR ROCK HOLDING CORPORATION Shares Outstanding (Cover Page)
SCHOLAR ROCK HOLDING CORPORATION (SRRK) had Shares Outstanding (Cover Page) of 121.79 million shares as of 2026-08-03, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-08-03: Entity Common Stock, Shares Outstanding 121.79M shares.
- 2026-05-04: Entity Common Stock, Shares Outstanding 119.83M shares.
- 2026-02-26: Entity Common Stock, Shares Outstanding 114.88M shares.
- 2025-11-05: Entity Common Stock, Shares Outstanding 102.01M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-03 | 121.79M shares 10-Q · filed 2026-08-06 |
| 2026-05-04 | 119.83M shares 10-Q · filed 2026-05-07 |
| 2026-02-26 | 114.88M shares 10-K · filed 2026-03-03 |
| 2025-11-05 | 102.01M shares 10-Q · filed 2025-11-14 |
| 2025-08-01 | 96.13M shares 10-Q · filed 2025-08-06 |
| 2025-05-12 | 94.95M shares 10-Q · filed 2025-05-14 |
| 2025-02-24 | 94.68M shares 10-K · filed 2025-02-27 |
| 2024-11-07 | 93.61M shares 10-Q · filed 2024-11-12 |
| 2024-08-02 | 80.03M shares 10-Q · filed 2024-08-08 |
| 2024-05-02 | 79.75M shares 10-Q · filed 2024-05-07 |
| 2024-03-14 | 77.87M shares 10-K · filed 2024-03-19 |
| 2023-11-02 | 72.14M shares 10-Q · filed 2023-11-07 |
| 2023-08-03 | 56.23M shares 10-Q · filed 2023-08-09 |
| 2023-05-04 | 54.29M shares 10-Q · filed 2023-05-09 |
| 2023-03-02 | 51.99M shares 10-K · filed 2023-03-07 |
| 2022-11-08 | 51.66M shares 10-Q · filed 2022-11-14 |
| 2022-08-03 | 51.64M shares 10-Q · filed 2022-08-08 |
| 2022-05-10 | 35.30M shares 10-Q · filed 2022-05-16 |
| 2022-03-02 | 35.30M shares 10-K · filed 2022-03-07 |
| 2021-11-04 | 35.11M shares 10-Q · filed 2021-11-09 |
| 2021-08-04 | 34.46M shares 10-Q · filed 2021-08-10 |
| 2021-05-10 | 34.42M shares 10-Q · filed 2021-05-13 |
| 2021-03-01 | 34.26M shares 10-K · filed 2021-03-09 |
| 2020-11-04 | 33.64M shares 10-Q · filed 2020-11-09 |
| 2020-08-03 | 29.87M shares 10-Q · filed 2020-08-07 |
| 2020-05-01 | 29.87M shares 10-Q · filed 2020-05-07 |
| 2020-03-01 | 29.81M shares 10-K · filed 2020-03-12 |
| 2019-11-01 | 29.68M shares 10-Q · filed 2019-11-12 |
| 2019-08-01 | 29.68M shares 10-Q · filed 2019-08-14 |
| 2019-05-01 | 26.23M shares 10-Q · filed 2019-05-15 |
| 2019-03-01 | 26.22M shares 10-K · filed 2019-03-19 |
| 2018-11-01 | 25.24M shares 10-Q · filed 2018-11-08 |
| 2018-08-03 | 25.24M shares 10-Q · filed 2018-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |